Even in case MYL management is sufficiently desperate to up the offer for PRGO in order to save their jobs, I think MYL shareholders would prefer Teva's offer.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.